| Thioredoxin domain-containing protein 9 protects cells against UV-B-provoked apoptosis via NF-kappaB/p65 activation in cutaneous squamous cell carcinoma. | Thioredoxin domain-containing protein 9 protects cells against UV-B-provoked apoptosis via NF-κB/p65 activation in cutaneous squamous cell carcinoma.
Xiao Z, Xu Q, Wang H, Zhou X, Zhu Y, Bao C, Chen L, Zhang P, Lin M, Ji C, Gong T., Free PMC Article | 06/21/2023 |
| TXNDC9 knockdown inhibits lung adenocarcinoma progression by targeting YWHAG. | TXNDC9 knockdown inhibits lung adenocarcinoma progression by targeting YWHAG.
Wang J, Pan X, Li J, Zhao J., Free PMC Article | 05/7/2022 |
| High level of TXNDC9 predicts poor prognosis and contributes to the NF-kappaB-regulated metastatic potential in gastric cancer. | High level of TXNDC9 predicts poor prognosis and contributes to the NF-κB-regulated metastatic potential in gastric cancer.
Yang QC, Hao N, Li RH, Duan YY, Zhang Y. | 02/19/2022 |
| Thioredoxin domain-containing protein 9 (TXNDC9) contributes to oxaliplatin resistance through regulation of autophagy-apoptosis in colorectal adenocarcinoma. | Thioredoxin domain-containing protein 9 (TXNDC9) contributes to oxaliplatin resistance through regulation of autophagy-apoptosis in colorectal adenocarcinoma.
Zhou W, Fang C, Zhang L, Wang Q, Li D, Zhu D. | 10/24/2020 |
| these studies demonstrate that the TXNDC9-PRDX1 axis plays an important role for ROS to activate AR functions. It provides a proof-of-principle that co-targeting AR and PRDX1 may be more effective to control prostate cancer (PCa) growth. | TXNDC9 regulates oxidative stress-induced androgen receptor signaling to promote prostate cancer progression.
Feng T, Zhao R, Sun F, Lu Q, Wang X, Hu J, Wang S, Gao L, Zhou Q, Xiong X, Dong X, Wang L, Han B. | 04/18/2020 |
| TXNDC9 promotes hepatocellular carcinoma progression by positive regulation of MYC-mediated transcriptional network. | TXNDC9 promotes hepatocellular carcinoma progression by positive regulation of MYC-mediated transcriptional network.
Chen D, Zou J, Zhao Z, Tang X, Deng Z, Jia J, Liu S., Free PMC Article | 12/14/2019 |
| These findings suggest that TXNDC9 gene may function in colorectalcancer development | TXNDC9 expression in colorectal cancer cells and its influence on colorectal cancer prognosis.
Lu A, Wangpu X, Han D, Feng H, Zhao J, Ma J, Qu S, Chen X, Liu B, Zheng M. | 03/23/2013 |
| PhLP3 is important for the maintenance of beta-tubulin levels in mammalian cells. | Modulation of phosducin-like protein 3 (PhLP3) levels promotes cytoskeletal remodelling in a MAPK and RhoA-dependent manner.
Hayes NV, Jossé L, Smales CM, Carden MJ., Free PMC Article | 04/28/2012 |
| antagonistic actions of PhLP3 and prefoldin serve to modulate CCT activity and play a key role in establishing a functional cytoskeleton in vivo | PhLP3 modulates CCT-mediated actin and tubulin folding via ternary complexes with substrates.
Stirling PC, Cuéllar J, Alfaro GA, El Khadali F, Beh CT, Valpuesta JM, Melki R, Leroux MR. | 01/21/2010 |